 Elizabeth Woodruff
Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ovarian Neoplasms | 11 | 2025 | 562 | 1.370 |
Why?
| | Circadian Rhythm | 7 | 2018 | 489 | 1.330 |
Why?
| | Period Circadian Proteins | 4 | 2018 | 31 | 1.320 |
Why?
| | Corticosterone | 6 | 2018 | 242 | 1.190 |
Why?
| | Prefrontal Cortex | 4 | 2018 | 306 | 1.000 |
Why?
| | Extinction, Psychological | 2 | 2018 | 88 | 0.970 |
Why?
| | Glucocorticoids | 4 | 2017 | 528 | 0.870 |
Why?
| | Fear | 2 | 2018 | 344 | 0.830 |
Why?
| | Suprachiasmatic Nucleus | 4 | 2017 | 18 | 0.750 |
Why?
| | ARNTL Transcription Factors | 3 | 2017 | 16 | 0.750 |
Why?
| | Circadian Clocks | 2 | 2017 | 56 | 0.640 |
Why?
| | Pituitary-Adrenal System | 3 | 2017 | 170 | 0.640 |
Why?
| | Hypothalamo-Hypophyseal System | 3 | 2017 | 205 | 0.630 |
Why?
| | Receptors, Steroid | 1 | 2017 | 46 | 0.550 |
Why?
| | Claudin-4 | 3 | 2025 | 13 | 0.490 |
Why?
| | Adrenalectomy | 6 | 2018 | 65 | 0.480 |
Why?
| | Adrenal Glands | 2 | 2017 | 75 | 0.480 |
Why?
| | Nerve Tissue Proteins | 1 | 2018 | 600 | 0.450 |
Why?
| | Stress, Psychological | 3 | 2017 | 1119 | 0.450 |
Why?
| | Genomic Instability | 2 | 2025 | 52 | 0.430 |
Why?
| | Cystadenocarcinoma, Serous | 3 | 2024 | 78 | 0.420 |
Why?
| | Poly(ADP-ribose) Polymerase Inhibitors | 3 | 2024 | 116 | 0.410 |
Why?
| | Histone-Lysine N-Methyltransferase | 2 | 2024 | 134 | 0.380 |
Why?
| | Rats, Sprague-Dawley | 6 | 2018 | 2499 | 0.320 |
Why?
| | Wnt Signaling Pathway | 2 | 2021 | 196 | 0.290 |
Why?
| | Endometrial Neoplasms | 2 | 2021 | 196 | 0.290 |
Why?
| | Proto-Oncogene Proteins c-fos | 2 | 2017 | 191 | 0.260 |
Why?
| | Polycomb Repressive Complex 1 | 2 | 2024 | 50 | 0.250 |
Why?
| | Tumor Microenvironment | 3 | 2024 | 669 | 0.240 |
Why?
| | Drug Resistance, Neoplasm | 3 | 2024 | 801 | 0.220 |
Why?
| | Cell Line, Tumor | 7 | 2025 | 3392 | 0.210 |
Why?
| | Tryptophan Oxygenase | 1 | 2024 | 34 | 0.210 |
Why?
| | Fallopian Tubes | 1 | 2024 | 32 | 0.210 |
Why?
| | Animals | 14 | 2024 | 37217 | 0.200 |
Why?
| | Paraventricular Hypothalamic Nucleus | 3 | 2017 | 33 | 0.200 |
Why?
| | Gene Expression Regulation, Neoplastic | 6 | 2025 | 1388 | 0.200 |
Why?
| | RNA, Messenger | 3 | 2018 | 2815 | 0.180 |
Why?
| | Autophagy | 1 | 2024 | 285 | 0.180 |
Why?
| | In Situ Hybridization | 3 | 2017 | 319 | 0.180 |
Why?
| | Wnt Proteins | 1 | 2021 | 135 | 0.160 |
Why?
| | Rats | 5 | 2018 | 5594 | 0.150 |
Why?
| | beta Catenin | 1 | 2021 | 252 | 0.150 |
Why?
| | Gene Expression Profiling | 2 | 2016 | 1746 | 0.140 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2024 | 905 | 0.140 |
Why?
| | Transduction, Genetic | 1 | 2018 | 136 | 0.140 |
Why?
| | Photoperiod | 2 | 2015 | 53 | 0.140 |
Why?
| | Septal Nuclei | 1 | 2017 | 24 | 0.130 |
Why?
| | Green Fluorescent Proteins | 1 | 2018 | 398 | 0.130 |
Why?
| | Immediate-Early Proteins | 1 | 2017 | 49 | 0.130 |
Why?
| | Mental Recall | 1 | 2018 | 207 | 0.130 |
Why?
| | Sexual Behavior, Animal | 1 | 2017 | 58 | 0.130 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2020 | 282 | 0.130 |
Why?
| | RNA, Small Interfering | 1 | 2018 | 626 | 0.120 |
Why?
| | Stress, Physiological | 2 | 2017 | 450 | 0.120 |
Why?
| | Feedback, Physiological | 1 | 2016 | 81 | 0.120 |
Why?
| | Brain | 3 | 2017 | 2792 | 0.120 |
Why?
| | Adrenocorticotropic Hormone | 1 | 2016 | 148 | 0.120 |
Why?
| | Freezing Reaction, Cataleptic | 1 | 2015 | 22 | 0.120 |
Why?
| | Oligodendroglia | 1 | 2017 | 177 | 0.110 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 2049 | 0.110 |
Why?
| | Auditory Perception | 1 | 2015 | 113 | 0.100 |
Why?
| | Acoustic Stimulation | 1 | 2015 | 319 | 0.100 |
Why?
| | Female | 15 | 2025 | 73763 | 0.100 |
Why?
| | Cues | 1 | 2015 | 319 | 0.090 |
Why?
| | Male | 8 | 2018 | 68260 | 0.080 |
Why?
| | Humans | 14 | 2025 | 138651 | 0.080 |
Why?
| | Mice | 5 | 2024 | 17814 | 0.080 |
Why?
| | Mutation | 1 | 2021 | 3987 | 0.080 |
Why?
| | Cell Survival | 2 | 2025 | 1123 | 0.080 |
Why?
| | Gene Expression Regulation | 1 | 2018 | 2590 | 0.080 |
Why?
| | Neoplasms | 1 | 2023 | 2681 | 0.070 |
Why?
| | Time Factors | 1 | 2018 | 6851 | 0.070 |
Why?
| | Restraint, Physical | 2 | 2017 | 73 | 0.060 |
Why?
| | Macrophages | 2 | 2024 | 1543 | 0.060 |
Why?
| | Micronuclei, Chromosome-Defective | 1 | 2024 | 7 | 0.060 |
Why?
| | Amino Acid Transport System ASC | 1 | 2024 | 12 | 0.050 |
Why?
| | Minor Histocompatibility Antigens | 1 | 2024 | 46 | 0.050 |
Why?
| | Histocompatibility Antigens | 1 | 2024 | 106 | 0.050 |
Why?
| | BRCA2 Protein | 1 | 2024 | 62 | 0.050 |
Why?
| | Anoikis | 1 | 2023 | 31 | 0.050 |
Why?
| | Polycomb-Group Proteins | 1 | 2023 | 28 | 0.050 |
Why?
| | Kynurenine | 1 | 2024 | 115 | 0.050 |
Why?
| | Tryptophan | 1 | 2024 | 183 | 0.050 |
Why?
| | X-ray Repair Cross Complementing Protein 1 | 1 | 2022 | 13 | 0.050 |
Why?
| | B7-H1 Antigen | 1 | 2024 | 216 | 0.050 |
Why?
| | Cell Cycle | 1 | 2025 | 592 | 0.050 |
Why?
| | Cell Nucleus | 1 | 2025 | 607 | 0.040 |
Why?
| | Heterocyclic Compounds, 3-Ring | 1 | 2021 | 32 | 0.040 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2024 | 870 | 0.040 |
Why?
| | Lysine | 1 | 2023 | 290 | 0.040 |
Why?
| | Indazoles | 1 | 2021 | 67 | 0.040 |
Why?
| | Enzyme Inhibitors | 1 | 2024 | 847 | 0.040 |
Why?
| | Sex Factors | 2 | 2017 | 2044 | 0.040 |
Why?
| | ErbB Receptors | 1 | 2023 | 609 | 0.040 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2024 | 525 | 0.040 |
Why?
| | DNA Repair | 1 | 2022 | 229 | 0.040 |
Why?
| | Imidazoles | 1 | 2021 | 239 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2024 | 785 | 0.040 |
Why?
| | DNA Damage | 1 | 2022 | 422 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2021 | 349 | 0.040 |
Why?
| | Molecular Targeted Therapy | 1 | 2021 | 413 | 0.040 |
Why?
| | Recurrence | 1 | 2021 | 1084 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2020 | 666 | 0.030 |
Why?
| | Pyridines | 1 | 2021 | 494 | 0.030 |
Why?
| | Genes, fos | 1 | 2017 | 37 | 0.030 |
Why?
| | Peptides | 1 | 2023 | 976 | 0.030 |
Why?
| | Disease Management | 1 | 2021 | 622 | 0.030 |
Why?
| | Rats, Inbred F344 | 1 | 2017 | 267 | 0.030 |
Why?
| | Corpus Callosum | 1 | 2017 | 70 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2024 | 2480 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2017 | 274 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2022 | 1057 | 0.030 |
Why?
| | Corticotropin-Releasing Hormone | 1 | 2016 | 75 | 0.030 |
Why?
| | Transcription Factors | 1 | 2023 | 1697 | 0.030 |
Why?
| | Hypothalamus | 1 | 2015 | 153 | 0.030 |
Why?
| | Cerebral Cortex | 1 | 2017 | 452 | 0.030 |
Why?
| | Prognosis | 1 | 2022 | 3984 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2024 | 4315 | 0.030 |
Why?
| | Motor Activity | 1 | 2017 | 710 | 0.020 |
Why?
| | Disease Progression | 1 | 2020 | 2749 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2015 | 1317 | 0.020 |
Why?
| | Biomarkers | 1 | 2024 | 4092 | 0.020 |
Why?
| | Gene Expression | 1 | 2017 | 1488 | 0.020 |
Why?
| | Genetic Variation | 1 | 2015 | 986 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2020 | 2152 | 0.020 |
Why?
| | Neurons | 1 | 2017 | 1601 | 0.020 |
Why?
|
|
Woodruff's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|